{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:04:57Z","timestamp":1783004697681,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jacasi.2025.01.018","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T19:08:39Z","timestamp":1744744119000},"page":"744-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Validation of High Ischemic and Bleeding Risk Criteria of European Guidelines in Peripheral Arterial Disease"],"prefix":"10.1016","volume":"5","author":[{"given":"Kayo","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikiyo","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakuramaru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raita","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacasi.2025.01.018_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2025.01.018_bib2","doi-asserted-by":"crossref","first-page":"e1553","DOI":"10.1016\/S2214-109X(23)00355-8","article-title":"Global burden of peripheral artery disease and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"11","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jacasi.2025.01.018_bib3","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/eurheartj\/ehp355","article-title":"Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry","volume":"30","author":"Alberts","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.01.018_bib4","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.01.018_bib5","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1136\/heartjnl-2019-316088","article-title":"Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease","volume":"106","author":"Hageman","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacasi.2025.01.018_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1253\/circj.CJ-19-1109","article-title":"JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease","volume":"84","author":"Nakamura","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.jacasi.2025.01.018_bib7","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.01.018_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12928-022-00873-z","article-title":"Two-year results of endovascular therapy for femoropopliteal artery disease in Japan during the introduction of drug-eluting devices","volume":"38","author":"Suzuki","year":"2023","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jacasi.2025.01.018_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12928-022-00896-6","article-title":"Impact of radial compression protocols on radial artery occlusion and hemostasis time in coronary angiography","volume":"38","author":"Takamatsu","year":"2023","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jacasi.2025.01.018_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12928-023-00948-5","article-title":"Hybrid treatment of distal bypass and pedal artery angioplasty following intraoperative direct puncture angiography for chronic limb-threatening ischemia with occult vessel","volume":"39","author":"Yu","year":"2024","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jacasi.2025.01.018_bib11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12928-024-00999-2","article-title":"Two-year outcomes of endovascular therapy for femoropopliteal arterial lesions for patients with high bleeding risk","volume":"39","author":"Shima","year":"2024","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jacasi.2025.01.018_bib12","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.01.018_bib13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 Cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2025.01.018_bib14","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jcin.2021.08.079","article-title":"Objective outcome measures for trials in patients with chronic limb-threatening ischemia across 2 decades: analysis and recommendations","volume":"14","author":"Lakhter","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.jacasi.2025.01.018_bib15","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Gornik","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.01.018_bib16","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2025.01.018_bib17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.01.018_bib18","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.01.018_bib19","doi-asserted-by":"crossref","first-page":"e1368","DOI":"10.4244\/EIJ-D-22-00475","article-title":"Validation of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in patients undergoing peripheral endovascular interventions","volume":"18","author":"Tomoi","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacasi.2025.01.018_bib20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrcardio.2014.104","article-title":"Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI","volume":"11","author":"Levine","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacasi.2025.01.018_bib21","article-title":"Racial disparity between the post-procedural outcomes among patients with peripheral artery disease: a systematic review and meta-analysis","volume":"48","author":"Jaiswal","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jacasi.2025.01.018_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jvs.2023.02.015","article-title":"Asian race is associated with peripheral arterial disease severity and postoperative outcomes","volume":"78","author":"Chen","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacasi.2025.01.018_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5551\/jat.63576","article-title":"Validation of the domestic high bleeding risk criteria for japanese patients with acute myocardial infarction","volume":"30","author":"Matsumoto","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacasi.2025.01.018_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00380-023-02303-3","article-title":"Diagnostic ability of Japanese version of high bleeding risk criteria for ischemic outcomes in patients with acute myocardial infarction","volume":"39","author":"Matsumoto","year":"2024","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jacasi.2025.01.018_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12928-023-00920-3","article-title":"Japanese high bleeding risk criteria status predicts low thrombogenicity and bleeding events in patients undergoing percutaneous coronary intervention","volume":"38","author":"Nakanishi","year":"2023","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jacasi.2025.01.018_bib26","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jacc.2019.07.065","article-title":"Major bleeding in patients with coronary or peripheral artery disease treated with rivaroxaban plus aspirin","volume":"74","author":"Eikelboom","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725001784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725001784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T18:28:46Z","timestamp":1748975326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374725001784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2772374725001784"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.01.018","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of High Ischemic and Bleeding Risk Criteria of European Guidelines in Peripheral Arterial Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}